Disclaimer: Trade names listed are for guidance only complete list of registered trade names are available through Saudi Food and Drug Authority site.
Formulary is a continually updated list of medications and related information, representing the clinical judgment of physicians, pharmacists, and other experts in the diagnosis, prophylaxis, or treatment of diseases and promotion of health.
CHI Formulary is an evidence-based disease focused open Formulary which provides an essential drug list, either prescription or over the counter (OTC), that is necessary to treat a certain disease. CHI Formulary Governance Committee (FGC) with the Pharmacy and Therapeutic committee (PTC) govern, maintain and continually update the Formulary to make sure that all SFDA drugs are available based on the most recent clinical national and international guidelines and the provided drugs are safe and effective for the community of Saudi Arabia
The Objective of this Formulary is to provide impartial and objective information to insurance companies in the Kingdom of Saudi Arabia, as well as to service providers and patients to promote safe, effective and rational use of medicines, which is based on evidence and global best practices. Other Rationalize use of medicine Promote the use of generics
The CHI Formulary is provided on an excel sheet platform that users can filter by Indication, ICD 10 AM code, Drug Pharmacological classes, Scientific name Scientific description code root, pharmaceutical form, pharmaceutical form code root, description code and, ATC code.
Formulary provides Appendices with various tables and protocols that users should refer to whenever mentioned in the notes. Hyperlinked Appendices are provided on a separate column for each disease or indication.
The CHI Formulary user guide can be accessed and downloaded through: (CHI Drug Formulary Master Excel sheet User Guide "PDF Link" )
The CHI List of Indications covered can be accessed and downloaded through: "PDF Link"
Medication Prescribing must be:
Share